Remyelinating drug could improve vision in patients with multiple sclerosis
UC Riverside-led mouse study stresses MS treatment should be started early
By Iqbal Pittalwala |
| Health
Should we be double masking?
UC Riverside epidemiologist answers this and other questions in Q&A
By Iqbal Pittalwala |
| Health
Biomedical scientist explains how Covid-19 vaccines work
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
By Iqbal Pittalwala |
| Health
Are people living with HIV more isolated during the pandemic?
A UC Riverside-led study, funded by Merck, is set to find out
By Iqbal Pittalwala |
| Health
School of Medicine to serve as lead site for clinical trial on stuttering
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
By Iqbal Pittalwala |
| Health
More than half of American adults with advanced multiple sclerosis report mistreatment by caregivers
UC Riverside-led study describes first published survey documenting nature and extent of caregiver mistreatment of this population
By Iqbal Pittalwala |
| Health
Observed COVID-19 variability may have underlying molecular sources
UC Riverside-led study shows how variations in SARS-CoV-2 host gene expression can be linked to variations in COVID-19 susceptibility and symptom severity
By Iqbal Pittalwala |
| Health
Impact of HPV vaccination mandates on social inequalities
Policy has limited impact on vaccine uptake because of individual decision making, study finds
By Iqbal Pittalwala |
| Health